In 2018, the IFF initiated a total 91 doping controls and there was one anti-doping rule violations in the IFF initiated tests.

Out of these 91 IFF tests, 54 tests were conducted in the IFF Events (in-competition tests) and 37 were IFF out-of-competition tests including five samples analysed for ESAs and six samples analysed for either GH/GHRFs. Two samples did also undergo further IRMS analysis.

Samples analysed for Erythropoiesis Stimulating Agents (ESAs, e.g. EPO) and Groth Hormone (GH)/Growth Hormone Releasing Factors (GHRFs) are on a 5 % level in floorball. This meets the requirements of the WADA Technical Document for Sport Specific Analysis (TDSSA). The objective of the TDSSA is to protect clean athletes by establishing Minimum Level Analysis for those prohibited substances that are at risk of abuse in particular sports.

The IFF Member Associations and/or National Anti-Doping Agencies have reported of one possible anti-doping rule violation. The appeal time for this case is currently pending and the decision will be made later.

IFF ADRV decision on sibutramine is found here.
The IFF doping control statistics are found here.